PUBLISHER: The Insight Partners | PRODUCT CODE: 1420196
PUBLISHER: The Insight Partners | PRODUCT CODE: 1420196
The Europe endoscopy procedures market is expected to grow from US$ 6,786.59 million in 2022 to US$ 11,582.84 million by 2030. It is estimated to grow at a CAGR of 6.9% from 2022 to 2030.
Technological Advancements Leading to Enhanced Applications Fuels to the Europe Endoscopy Procedures Market
On April 12, 2021, Cosmo Pharmaceuticals NV announced the FDA approval of the GI Genius intelligent endoscopy system, its revolutionary device for lesion detection during colonoscopy. The device is the first of its kind to obtain the FDA approval through the De Novo application. The device operates in real time to assist the endoscopist in the detection of lesions, is very simple to use and is compatible with all endoscopes. Cosmo is the sole manufacturer. On December 2019, Boston Scientific Corporation launched "EXALT Model D" a Single-Use Duodenoscope for endoscopic retrograde cholangiopancreatography procedures. This is the world's first single use duodenoscope. The third generation EXALT Model D Single-Use Duodenoscope has incorporated several design updates based on physician feedback that are intended to improve the overall user experience. Thus, all these recent developments are expected to provide growth opportunities for the market over the forecast period.
Europe Endoscopy Procedures Market Overview
The Europe endoscopic procedures market is segmented into France, Germany, the UK, Spain, Italy, and the Rest of Europe. National healthcare systems in Europe are continuously changing, reorganizing, and adapting to changing demographics and budget restrictions. The region also utilizes technologically advanced approaches for treating chronic diseases.
Europe Endoscopy Procedures Market Revenue and Forecast to 2030 (US$ Million)
Europe Endoscopy Procedures Market Segmentation
The Europe endoscopy procedures market is segmented into procedure, offering, product type, and end user.
Based on procedure, the Europe endoscopy procedures market is segmented into endoscopic retrograde cholangiopancreatography (ERCP), endoscopic submucosal dissection (ESD), peroral endoscopic myotomy (POEM), endoscopic ultrasound (EUS), interventional pulmonology and laparoscopy, arthroscopy and bronchoscopy, colonoscopy and colposcopy, proctoscopy and thoracoscopy, and others. The others segment held the largest share of the Europe endoscopy procedures market in 2022.
Based on offering, the Europe endoscopy procedures market is segmented endoscopes, ERCP accessories, visualization system, head positioner and endotherapy injection needles, sampling device and device clip and electrosurgical knife, endoscopic ultrasound guided devices, guidewire, forceps, snare, irrigation/insufflation tubing systems, probes, hemostats clip, polyps' traps, single-use valves, trocar sleeves and tissue scissors and cutters, retrieval devices, and others. The endoscopes segment held the largest share of the Europe endoscopy procedures market in 2022.
Based on product type, the Europe endoscopy procedures market is bifurcated into disposable and reusable. The reusable segment held a larger share of the Europe endoscopy procedures market in 2022.
Based on end user, the Europe endoscopy procedures market is segmented into hospitals and clinics, ambulatory surgical centres, diagnostic laboratories, and others. The hospitals and clinics segment held the largest share of the Europe endoscopy procedures market in 2022.
Based on country, the Europe endoscopy procedures market is segmented int o the UK, Germany, France, Italy, Spain, and the Rest of Europe. The Rest of Europe dominated the Europe endoscopy procedures market in 2022.
Stryker Corp, Merit Medical Systems Inc, Smith & Nephew Plc, Arthrex Inc, Steris Plc, Conmed Corp, Olympus Corp, Boston Scientific Corp, and Cook Medical LLC, are some of the leading companies operating in the Europe endoscopy procedures market.